We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Special ReportOpen Accesscc iconby icon

Multifaceted role of clay minerals in pharmaceuticals

    Inderpreet Singh Khurana

    Department of Pharmaceutical Sciences & Drug Research, Punjabi University, Patiala 147002, India

    ,
    Satvinder Kaur

    GHG Khalsa College of Pharmacy, Gurusar Sadhar 141104, District Ludhiana, India

    ,
    Harpreet Kaur

    Department of Botany, GHG Khalsa College, Gurusar Sadhar 141104, District Ludhiana, India

    &
    Rajneet Kaur Khurana

    *Author for correspondence:

    E-mail Address: khurana.neeti@gmail.com

    University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India

    Published Online:https://doi.org/10.4155/fso.15.6

    Abstract

    The desirable physical and physiochemical properties of clay minerals have led them to play a substantial role in pharmaceutical formulations. Clay minerals like kaolin, smectite and palygorskite-sepiolite are among the world's most valuable industrial minerals and of considerable importance. The elemental features of clay minerals which caused them to be used in pharmaceutical formulations are high specific area, sorption capacity, favorable rheological properties, chemical inertness, swelling capacity, reactivity to acids and inconsiderable toxicity. Of course, these are highly cost effectual. This special report on clay minerals provides a bird's eye view of the chemical composition and structure of these minerals and their influence on the release properties of active medicinal agents. Endeavor has been made to rope in myriad applications depicting the wide acceptability of these clay minerals.

    With a variegated range of physical, chemical and physicochemical properties, clay minerals have an undisputable role in pharmaceutical industries. The minerals employed primarily are oxides, carbonates, sulphates, chlorides, hydroxides, sulphides, phosphates, nitrates, borates and phyllosilicates. These are widely put into use owing to their unique features. The significant contributions of these minerals are in therapeutic, cosmetics and as bulk forming agents. These are biologically compatible and hence ensure the genesis of safe and effective drug delivery systems.

    Figure 1. Basic composition of clay minerals.

    Diagrammatic representation of the (A) octahedral sheet and (B) tetrahedral sheet.

    Figure 2. Classification of clay minerals.

    Clay, a group of natural minerals with plastic properties are primarily composed of hydrous-layer silicates of aluminium, occasionally containing magnesium and iron particles of smaller size, in other words, less than 2 μm (7.9 × 10−5 inch). Hence, in broader terms, clay minerals practically involve minerals of the above-cited particles size. These are essentially composed of silica, alumina, magnesia, iron and water with varying degree of potassium, sodium and calcium [1].

    Besides clay minerals no other minerals quite as immensely attract pharma people. Since the 19th century clay minerals have been explored on the geological, geotechnical and mineralogical fronts; their myriad therapeutic aspects were highlighted primarily in the pharmaceutical research. Clay minerals are a class of phyllosilicates which usually form as a result of chemical weathering of silicate minerals at the surface of the Earth [2]. Clay minerals are widely used in the pharmaceutical industry as lubricants, desiccants, disintegrants, diluents, binders, pigments and opacifiers. The other vital uses are as emulsifying, thickening, isotonic and anticaking agents. These also serve as flavor correctors and carriers of active ingredients. Other unique features are dispersivity, hygroscopicity, unctuosity, thixotropy and their rendering a slightly alkaline reaction as pH is slightly more than 7, plasticity, opacity and various high-quality colors [3].

    Composition & structural features of clays

    Clay minerals are primarily of a fine-grained natural material with particle size <2 μm [4]. The physical and chemical properties of a particular clay mineral are dependent on its structure and composition. The structure and composition of the major industrial clays, in other words, kaolins, smectites and palygorskite–sepiolite, are very different even though each is comprised of octahedral and tetrahedral sheets as their basic building blocks. However, the arrangement and composition of the octahedral and tetrahedral sheets, as depicted in Figure 1, account for most differences in their physical and chemical properties [5]. Clay minerals are stacked, polymeric sandwiches of tetrahedral and octahedral sheet structures. They are classified first into ‘layer types,’ differentiated by the number of tetrahedral and octahedral sheets that have combined, and then into ‘groups,’ differentiated by the kinds of isomorphic cation substitution that have occurred [6,7]. Clay minerals can be classified into seven groups as illustrated in Figure 2. Thus, mineral products for pharmaceutical use vary according to composition, crystallinity, habit and texture, greatly affecting their properties [8]. The individual layers of clay minerals are composed of two, three or four sheets [9]. The sheets are formed either by tetrahedrons [SiO4]4-, abbreviated as ‘T’ or by octahedrons, for example, [AlO3(OH)3]6-, abbreviated as ‘O.’ The interior of tetrahedrons and octahedrons contain smaller metal cations, their apices being occupied by oxygen, which are with protons (as OH). All these fundamental structural elements are arranged to form a hexagonal network in each sheet. Based on the number and the ratio of sheets in a fundamental structural layer, the existing cation substitutions in the octahedrons and tetrahedrons and based on the resulting charge of the layers, the crystalline clay minerals are classified [10]. A detailed description of the chemical composition of the various clay minerals is given in Table 1.

    Some predominantly employed clay minerals are kaolinite, 2SiO2·Al2O3·2H2O; pyrophyllite, 4SiO2·Al2O3·H2O; talc, 4SiO2·3MgO·H2O and chamosite, 3SiO2·Al2O3·5FeO·4H2O. The SiO2 ratio in a formula is the key factor determining clay mineral types [1].

    A sneak peek into the open-ended research on clay minerals

    Clay minerals are used as excipients in pharmaceutical preparations to enhance their organoleptic characteristics, such as flavor (flavor correctors) and color (pigments), improve their physicochemical properties, such as viscosity of the active ingredients (emulsifying, thickening and anticaking agents), facilitate their elaboration (lubricants, diluents, binders, isotonic agents) or conservation (desiccants, opacifiers) and facilitate liberation of the active ingredient within the organism (disintegrants, carrier releasers) [3].

    Clay minerals with very fine, thin particles and high adsorbent properties are quite useful for the antibiotics sorption. Kim et al. studied the sorption of oxytetracycline on clay minerals especially in acidic soils with high organic matter content [10]. The adsorption of four widely used drugs, carbamazepine, diclofenac, ibuprofen and ketoprofen, was investigated onto a porous silica under varied ionic strengths, and with different anions, divalent cations (Ca2+ and Mg2+), trivalent cations (Al3+ and Fe3+) and natural organic matter. The studies demonstrated that at a given pH the adsorption was most affected by ionic strength, trivalent cations and properties of pharmaceuticals. The increase of ionic strength resulted in an increase in the adsorption of ketoprofen, but a decrease in the adsorption of carbamazepine [11]. Cation exchange was the major mechanism of ciprofloxacin desorption from clay mineral surface. Ciprofloxacin desorption from kaolinite and montmorillonite was investigated under different pHs, different concentrations of metal cations of various valencies (Na+, Ca2+ and Al3+) and a cationic surfactant hexadecyl trimethylammonium (HDTMA), with different desorption cycles [12]. Enhanced desorption hysteresis of carbamazepine was observed for the smectites with negatively charged sites compensated with inorganic cations such as K+, Ca2+ and NH4+ than the desorption from organic cation-modified smectites (e.g., HDTMA clay), suggesting that the intercalated carbamazepine molecules are more resistant to release than carbamazepine partitioning in alkyl organic phase [2]. In addition, the large cation exchange capacity and surface area make the clay a good candidate to remove cationic pharmaceuticals from the effluent of waste water treatment facilities [13]. The protein adsorption capacity and selectivity of kaolinite and metakaolinite show a clear dependence on the chemical nature of the adsorbents surface and on the textural properties. Kaolinite and metakaolinite exhibit a very high affinity and good retention capacity for proteins like bovine serum albumin specially A-LA and B-LG [14]. The clay/poly(N-isopropylacrylamide) (PNIPAm) nanocomposite hydrogels, using lithium magnesium silicate hydrate as a clay mineral physical cross-linker were prepared to remove crystal violet from aqueous solution [15]. Similarly, Ballav and associates studied the absorption behavior of polypyrrole-coated halloysite nanotube nanocomposite [16]. Recently, clays have been modified through several approaches like conventional ion exchange reactions, sol-gel linking, atom transfer radical polymerization and polymer intercalation. The organic interaction incorporates different noncovalent bonding forces, such as amido acid five-membered ring chelation, carboxylic acid chelation, intermolecular hydrogen bonding and double-layer hydrophobic alignment in a layered clay confinement. Furthermore, the layered structure could be totally exfoliated and structurally randomized into individual silicate platelets using different mechanisms, such as the phase inversion of amphiphilic copolymer emulsifiers and phase transitions that involve zigzag Mannich polyamines. Different intercalation and exfoliation strategies help in developing detailed understanding of clay chemistry, thus exploring wider horizons of clay applications [17].

    Clay minerals sorption activity is the most suitable application in veterinary science. Kaolins and smectites are most commonly used in animal nutrition as growth promoters and supplements for the treatment of gastrointestinal disturbances, particularly diarrhea [18].

    The antibacterial activity of silver and cationic surfactant modified smectites from North Patagonia, Argentina, were tested in growth inhibition of Escherichia coli bacteria by the test of susceptibility on solid medium [19]. Minerals also enjoy diagnostic, odontological and traumatological applications, and are used in spas and aesthetic centers for therapeutic proposes [20]. Research focused on the role of clay minerals in kerogen formation, kerogen conversion to petroleum, oil migration and entrapment in reservoirs identify significant interactions arising from the adsorptive and catalytic properties of clay minerals and structural changes during diagenetic transformations [21]. Recently, Das et al., 2014 explored the significant antibacterial activity of copper nanoparticle-decorated organically with modified montmorillonite/epoxy nanocomposites against ubiquitous Gram- negative bacteria Klebsiella pneumonia and Gram-positive bacteria Staphylococcus aureus [22].

    Kaolinite, talc, palygorskite and smectites are used for therapeutic purposes in pharmaceutical formulations as active principles or excipients. The possible use of sepiolite as active principle or excipient in pharmaceutical formulations was also investigated. Kaolinite, talc, palygorskite and smectites are used as excipients in cosmetics and pharmaceutical preparations [23]. A summary of the pharmacological activities of the clay minerals is described in Table 2. They also have an admirable role in the targeted and modified drug delivery system as in Table 3.

    Conclusion & future perspective

    Research trends on clay minerals are heading toward the synthesis of minerals based on atomic and molecular scale design by affecting their physicochemical properties and thus they have a wide scope of applications in pharmaceutics. Chemical and physical interactions of clays with water and many other chemical species, and their dynamics, offer further scope. Biological implications related to clays are likely to be investigated more extensively. Novel materials based on nanotechnology, biochemical and medical applications, and environmental aspects are envisaged [55]. Chemically modified clay mineral electrodes are also being explored for many chemical sensor applications. Tuning the process and coupling it with a separation technique can achieve effective DNA quantification. Because of the stability of clays, combining them with enzymes and suitable redox mediators – for example, clay in conjunction with hydroquinone mediator – could be a new way to quantify microbiological systems such as fungi and bacteria such as Escherichia coli [56]. Novel-layered nanohybrid materials with controlled functions and microstructures are also being extensively explored. Nanocomposites based on clays and organic compounds are expanding. Studies of domain structures in layer silicates will continue, and further refinements in mixed-layer structure analysis can be expected. The study of clay mineral synthesis and alteration in nature shows signs of important reactivation. Furthermore, the self-assembled film of clay minerals has a highly regular multilayered nanostructure over a large area and could appreciably entrap in between the volume of air [57]. The combination of regular structure and substantial air volume contributes to the low thermal conductivity and flame blocking property of the film.

    Clay-organic studies are developing in many directions. An understanding of the surface chemistry, particle shape and relative size distribution are crucial in developing such materials for an increasingly demanding and diverse world [58]. Organo-clays receive great interest for applications based on their capacity for selective adsorption of molecules. Thus, they have been used for application in chromatography separations, to remove organic pollutants from air and water, and to develop improved formulation for pesticides, as chemical sensor and molecular sieves, and so on. Among other properties applications based on special structural, gas barrier, antiflammability or others can be mentioned. Interesting photochemical behavior may also arise from the specific structure of those nanocomposites. Depending on the layer structure and specific properties, such as high-specific surface area, ion exchange capacity or hydration property, clay minerals are widely used in pharmaceuticals, and as adsorbents, catalysts or catalyst supports, ion exchangers and decolorizing agents.

    Table 1. Chemical composition of clay minerals.
    GroupChemical formulaeOctahedral characterStructure
    Kaolinite-serpentineAl2Si2O5(OH)4Trioctahedral dioctahedral ditriotahedralTwo-sheet phyllosilicates, where the T:O ratio = 1: 1 and the charge of the two-sheet layer = 0
    Pyrophyllite-talcAl2Si4O10(OH)2 Mg3Si4O10(OH)2Trioctahedral dioctahedralNonswelling three-sheet phyllosilicates, where the T:O ratio = 2:1 and the charge of the three-sheet layer = 0
    SmectiteMontmorillonite: (Al1.67Mg0.33)Si4O10(OH)2M+0.33Trioctahedral dioctahedralStrongly expanding three-sheet phyllosilicates, where the T:O ratio = 2:l and the charge of the three-sheet layer = 0.5–1.2
     Saponite: Mg3(Si3.67Al0.33)O10(OH)2M+0.33  
     Hectorite: (Mg,Li)3(Si,Al)4O10(OH)2M+0.33  
    Vermiculite(Mg,Fe,Al)3(Al,Si)4O10(OH)2·4H2OTrioctahedral dioctahedralThe expanding three-sheet phyllosilicates, where the T:O ratio = 2:1 and the charge of the three-sheet layer = 1.2–1.8
    Mica/IlliteKAl2(Si3Al)O10(OH)2Trioctahedral dioctahedral trioctahedralThree-sheet phyllosilicates, where the T:O ratio = 2:1 and the charge of the three-sheet layer ≤2
    ChloriteAl4[Si8O20](OH)4Al4( OH)12Trioctahedral dioctahedral ditriotahedralFour-sheet silicates, where the T:O:O ratio = 2:1:1 and the charge of the four-sheet layer is 1.1–3.3
    Palygorskite- sepiolite group(Mg,Al,Fe3+)5(Si,Al)8O20(OH)2(OH2)4.4H2O Mg8Si12O30(OH)4(OH2)4·8H2OTrioctahedral dioctahedralPalygorskite and sepiolite are phyllosilicates inas- much as they contain a continuous 2D tetrahedral sheet; however, they differ from other layer silicates in that they lack continuous octahedral sheets
    Table 2. Pharmaceutical activity of clay minerals.
    GroupPharmaceutical activityMechanism of actionRef.
    Palygorskite-sepiolite, smectitesGastric and duodenal ulcerH+ neutralizing capacity decomposition in gastric acid and bring the bowel pH to 6[24]
    Kaolinite palygorskite-sepiolite, smectitesGastrointestinal protectorHigh-specific area and sorption capacity[25]
    Palygorskite-sepiolite, smectites, kaoliniteAntidiarrhoeaicsAstringent action of the Ca2+ ion, which forms nonsoluble, hydrated phosphates[26]
    Kaolinite-talc, smectitesDermatological protectorsAdhere to skin, forming a film that mechanically protects the skin. Adsorbs the skin's secretions, and creates a large surface for their evaporation which promotes a gentle antiseptic action by producing a water poor medium that is unfavorable for the development of bacteria[27]
    Mirabilite, epsomite, periclase brucite, magnesiteLaxativesHigh solubility in water and HCl; release of Na+ or Mg2+ ions and nontoxic anions when ingested[28]
    KaoliniteAnti-inflammatories and local anestheticsHigh absorption and heat retention capacities[19]
    Palygorskite, sepiolite, kaolinite, smectites, talcCosmetic creams, powders and emulsionsOpacity and high sorption capacity[29]
    Silver and cationic surfactant-modified smectitesAntibacterial activityHeavy metals modified montmorillonites exhibit high cation exchange capacity, large specific surface and colloid properties that give rise to optimum adsorbents of organic and inorganic substances[30]
    Halite, sylvite, melanterite, epsomite, mirabilliteHomeostaticsSmectite group of minerals have wider applications due to their high swelling and cation exchange capacity[28]
    Table 3. Applications of clay minerals in drug delivery.
    Type of drug-delivery systemNatural minerals employedMechanismRef.
    Extended release systemsSmectites montmorillonite fibrous minerals HydrotalciteThey can retain large amounts of drug due to their high cation exchange capacity[31–38]
    Targeted delivery systemsNatural, synthetic, nanocomposites clay-polymers, films and hidrogels composites clay-polymersInteract with drugs reducing their absorption. Therefore, such interactions can be used to achieve technological and biopharmaceutical advantages, regarding the control of release.[39]
    Colon delivery systemsMontmorillonitePharmaceutical natural minerals and drug interactions[40,41]
    Periodontal systemsLaminar mineralsImproved bioadhesion[42,43]
    Hydration-activated extended release systemsSmectitesAct as disintegrant agents in tablet formulations because of their hydrophilic and swelling properties[44–46]
    MicroparticlesAmorphous silica bentonite attapulgite kaolin talcEncapsulation of surface, precipitation inclusion and phamaceutical natural minerals–polymer interaction[47–50]
    NanoparticlesHalloysite montmorillonites Bentonite porous silicaPharmaceutical natural minerals provide spontaneous submicron dispersions in aqueous media, resulting in low cost and biocompatible systems with large surface area and high-inclusion capacity[16,22,51]
    Encapsulation of drugs inside layered double hydroxides (LDHs) with Mg2+, Al3+ and Fe3+ in the layersHydrotalciteHydrotalcite-layered solids with positively charged layers and charge-balancing anions in the interlayer space which protects drugs like nonsteroidal anti-inflammatory drugs in the GI tract[52]
    Cellular uptakeHydrotalcite-derived antacidic and antipeptic formulationsLayered double hydroxides as nonviral vectors for delivery of antisense oligonucleotides[53]
    Silver nanoparticles and multiwalled carbon nanotubesMontmorilloniteTransfection studies of these various functionalized nanopreparations implied that the gene delivery vector based on silver nanoparticles stabilized with starch and montmorillonite were more promising[54]

    Executive summary

    Unique features of clay minerals in pharmaceutical industry

    • • The enormous surface area, surface chemistry and surface charge impart significant and unique physical properties to the clay minerals, owing to which these possess tremendous scope to be utilized as therapeutic, cosmetics, functional, inert and bulk agents.

    • • Most commonly employed clay minerals in pharmaceuticals and cosmetics are kaolinite, talc, montmorillonite, saponite, hectorite, palygorskite and sepiolite.

    • • Precisely clay minerals serve as lubricants, desiccants, disintegrants, diluents, binders, pigments and opacifiers. The other imperative one are emulsifying, thickening, isotonic and anticaking agents.

    • • The predominant curative properties include antacids, gastrointestinal protectors, antidiarrheaics, laxatives, homeostatics, emetics, antianemics and so on.

    Financial & competing interests disclosure

    The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

    No writing assistance was utilized in the production of this manuscript.

    Open Access

    This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

    Papers of special note have been highlighted as: • of interest; • • of considerable interest

    References

    • 1 Grim RE. Clay minerals. Encylopedia Britannica. http://www.britannica.com/EBchecked/topic/120723/clay-mineral.Google Scholar
    • 2 Zhang W, Ding Y, Boyd SA, Teppen BJ, Li H. Sorption and desorption of carbamazepine from water by smectite clays. Chemosphere 81, 954–960 (2010).Crossref, Medline, CASGoogle Scholar
    • 3 Carretero MI, Pozo M. Clay and non-clay minerals in the pharmaceutical industry: Part I. Excipients and medical applications. Appl. Clay Sci. 46, 73–80 (2009).Crossref, CASGoogle Scholar
    • 4 Guggenheim S, Adams JM, Bain DC et al. Summary of recommendations of nomenclature committees relevant to clay mineralogy: report of the Association Internationale pour l'Etude des Argiles (AIPEA) Nomenclature Committee for 2006. Clay Minerals 41, 863–877 (2006).Crossref, CASGoogle Scholar
    • 5 Murray HH. Applied Clay Mineralogy – Occurrences, Processing and Application of Kaolins, Bentonites, Palygorskite-Sepiolite, and Common Clays. 141–145 (2006). In: Developments In Clay Science. (Volume 2). Bergaya F, Theng BKG, Lagaly G (Eds), Elsevier, The Netherlands.• Basics of clay mineralsCrossrefGoogle Scholar
    • 6 Sposito G, Skipper NT, Sutton R, Park SH, Soper AK, Greathouse JA. Surface geochemistry of the clay minerals. Proc. Natl Acad. Sci. USA 96, 3358–3364 (1999).Crossref, Medline, CASGoogle Scholar
    • 7 Liu H, Shen T, Li T, Yuan P, Shi G, Bao X. Green synthesis of zeolites from a natural aluminosilicate mineral rectorite: effects of thermal treatment temperature. Appl. Clay Sci. 90, 53–60 (2014).Crossref, CASGoogle Scholar
    • 8 Viseras C, Lopez-Galindo A. Pharmaceutical applications of some spanish clays _sepiolite, palygorskite, bentonite/: some preformulation studies. Appl. Clay Sci. 14, 69–82 (1999).Crossref, CASGoogle Scholar
    • 9 Konta J. Clay and man: clay raw materials in the service of man. Appl. Clay Sci. 10, 275–335 (1995).Crossref, CASGoogle Scholar
    • 10 Kim YK, Lim SJ, Han MH, Cho JY. Sorption characteristics of oxytetracycline, amoxicillin, and sulfathiazole in two different soil types. Geoderma 185, 97–101 (2012).CrossrefGoogle Scholar
    • 11 Bui TX, Choi H. Influence of ionic strength, anions, cations, and natural organic matter on the adsorption of pharmaceuticals to silica. Chemosphere 80, 681–686 (2010).• Basics of clay minerals.Crossref, Medline, CASGoogle Scholar
    • 12 Wu LM, Zhou CH, Keeling J, Tong DS, Yu WH. Towards an understanding of the role of clay minerals in crude oil formation, migration and accumulation. Earth Sci. Rev. 115, 373–386 (2012).Crossref, CASGoogle Scholar
    • 13 Zhaohui L, Chang PH, Jiang WT, Jean JS, Hong H, Liao L. Removal of diphenhydramine from water by swelling clay minerals. J. Colloid Interface Sci. 360, 227–232 (2011).Crossref, MedlineGoogle Scholar
    • 14 Duarte-Silva R, Villa-García MA, Rendueles M, Díaz M. Structural, textural and protein adsorption properties of kaolinite and surface modified kaolinite adsorbents. Appl. Clay Sci. 90, 73–80 (2014).Crossref, CASGoogle Scholar
    • 15 Zhang Q, Zhang T, He T, Chen L. Removal of crystal voilet by clay/PNIP Am nanocomposite hydrogels with various clay contents. Appl. Clay Sci. 90, 1–5 (2014).Crossref, CASGoogle Scholar
    • 16 Ballav N, Choi HJ, Mishra SB, Maity A. Polypyrrole-coated halloysite nanotube clay nanocomposite: synthesis, characterization and Cr (VI) adsorption behaviour. Appl. Clay Sci. 102, 60–70 (2014).Crossref, CASGoogle Scholar
    • 17 Wang YC, Huang TK, Tung SH, Wu TM, Lin JJ. Self-assembled clay films with a platelet–void multilayered nanostructure and flame-blocking properties. Sci. Rep. 3, 2621 (2013).Crossref, MedlineGoogle Scholar
    • 18 Slamova R, Trckova M, Vondruskova H, Zraly Z, Pavlik I. Clay minerals in animal nutrition. Appl. Clay Sci. 51, 395–398 (2011).Crossref, CASGoogle Scholar
    • 19 Parolo ME, Fernández LG, Zajonkovsky I, Sánchez MP, Baschini M. Science against microbial pathogens: communicating current research and technological advances. In: Antibacterial Activity of Materials Synthesized from Clay Minerals. Vilas AM (Ed.). FORMATEX, 144–151 (2011). http://www.formatex.info/microbiology3/book/144–151.pdf.Google Scholar
    • 20 Viseras C, Aguzzi C, Cerezo P, Lopez-Galindo A. Uses fo clay minerals in semisolid health care and therapeutic products. Appl. Clay Sci. 36, 37–50 (2007).• Highlights the role of clay minerals in therapeutics.Crossref, CASGoogle Scholar
    • 21 Wu Q, Li Z, Hong H, WT R. Desorption of ciprofloxacin from clay mineral surfaces. Water Res. 47, 259–268 (2013).Crossref, Medline, CASGoogle Scholar
    • 22 Das G, Kalita RD, Gogoi P, Buragohain AK, Karak N. Antibacterial activities of copper nanoparticle-decorated organically modified montmorillonite/epoxy nanocomposites. Appl. Clay Sci. 90, 18–26 (2014).Crossref, CASGoogle Scholar
    • 23 Bergaya F, Lagaly G (Eds). General Introduction: Clays, Clay Minerals, and Clay Science. In: Handbook of Clay Science (Volume 1). Theng BKG. Elsevier, Amsterdam, The Netherlands, 1–19 (2006).CrossrefGoogle Scholar
    • 24 Robert M F, Elsass F, Hardy M. Crystallochemistry, Properties and Organization of Soil Clays Derived from Major Sedimentary Rocks in France. Clay Minerals 26, 409–420 (1991).Crossref, CASGoogle Scholar
    • 25 Carretero MI, Gomes CSF, Tateo F. Clays and Human Health. In: Handbook of Clay Science (Volume 1). Bergaya F, Theng BKG, Lagaly G (Eds). Elsevier, 717 (2006).• Basics of clay minerals.CrossrefGoogle Scholar
    • 26 Murray HH. Traditional and new applications for kaolin, smectite, and palygorskite: a general overview. Appl. Clay Sci. 17, 207–221 (2000).• Basics of clay minerals.Crossref, CASGoogle Scholar
    • 27 Arab S, Alshikh A. The use of Clay Minerals of the Dead Sea as Drugs. In: Clay Minerals (Volume 5). Murray HH (Ed), NY, USA 5, 112–115 (2012).Google Scholar
    • 28 Silva PSC, Oliveira SMB, Farias L, Fávaro DIT, Mazzilli BP. Chemical and radiological characterization of clay minerals used in pharmaceutics and cosmetics. Appl. Clay Sci. 52, 145–149 (2011).Crossref, CASGoogle Scholar
    • 29 Carretero MI, Pozo M. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients. Appl. Clay Sci. 47, 171–181 (2010).• Highlights the role of clay minerals in Pharmaceutical sciences.Crossref, CASGoogle Scholar
    • 30 Williams LB, Haydel SE. Evaluation of the medicinal use of clay minerals as antibacterial agents. Int. Geol. Rev. 52, 745–770 (2010).Crossref, MedlineGoogle Scholar
    • 31 Maheshwari RK, Sharma SN, Jain NK. Adsorption studies of phenformin hydrochloride on some clays and its application in formulating sustained release dosage forms. Ind. J. Pharm. Sci. 50, 101–105 (1988).CASGoogle Scholar
    • 32 Forni F, Iannuccelli V, Cameroni R, Coppi G, Bernabei MT. Swellable heterogeneous matrixes: physical properties and release mechanisms. Farmaco Prat. 41, 155–164 (1986).Medline, CASGoogle Scholar
    • 33 Forni F, Iannuccelli V, Coppi G, Bernabei MT. Effect of montmorillonite on drug release from polymeric matrices. Arch. Pharm. 322, 789–793 (1989).Crossref, Medline, CASGoogle Scholar
    • 34 Aguzzi C, Viseras C, Cerezo P, Rossi S, Ferrari F, Caramella C. Control of tetracyclines delivery by their interaction with veegum. In: Proceedingsa of the 30th Annual Meeting & Exposition of the Controlled Release Society. 19–23 July (Glasgow, Scotland, UK (2003). Abstract 730).Google Scholar
    • 35 Aguzzi C, Viseras C, Cruz J, Zafra M, Cerezo P, Rossi S. Development of new controlled release systems based on mineral supports: III. Release studies of tetracyclines–silicate interaction products. Proceedings Of The 1st Eufeps Conference On Optimising Drug Delivery And Formulation: New Challenges In Drug Delivery. Acta del Congreso, Versailles, 136–137 (2003).Google Scholar
    • 36 Cerezo P. Mecanismos Y Cineticas De Adsorcion-Liberacion De Farmacos En Soportearcilloso. Contribución Al Estudio De Complejostimololmaleato Con Esmectitas, Paligorskitas Y Sepiolitas. University of Granada, Granada (E), [PhD thesis] (2003).Google Scholar
    • 37 Ambrogi V, Fardella G, Grandolini G, Perioli L. Intercalation compounds of hydrotalcite-like anionic clays with antinflammatory agents. I. Intercalation and in release of ibuprofen. Int. J. Pharm. 220, 23–32 (2001).Crossref, Medline, CASGoogle Scholar
    • 38 Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite-like anionic clays with antinflammatory agents. II. Uptake of diclofenac for a controlled release formulation. AAPS PharmSci Tech. 3, E26 (2002).Crossref, MedlineGoogle Scholar
    • 39 Rodrigues LA A, Veiga F, de Freitas RM et al. The systems containing clays and clay minerals from modified drug release: a review. Colloids Surf. B Biointerfaces 103, 642–651 (2013).• Highlights the role of clay minerals in drug delivery.Crossref, Medline, CASGoogle Scholar
    • 40 Shrivastava R, Jain SR, Frank SG. Dissolution dialysis studies of metronidazole–montmorilloniteadsorbates. J. Pharm. Sci. 74, 214–216 (1985).Crossref, Medline, CASGoogle Scholar
    • 41 Lin FH, Lee YH, Jian CH. A study of purified montmorillonite intercalated with 5-fluorouracile as drug carrier. Biomaterials 23, 1981–1987 (2002).Crossref, Medline, CASGoogle Scholar
    • 42 Aguzzi C, Ferrari F, Gatti A, Rossi S, Bonferoni MC, Cerezo P. Novel controlled release formulations based on tetracycline–clay interaction products for periodontal administration. Proceedings of the 45th Simposio AFI. Rimini Italy (2005). 177.Google Scholar
    • 43 Aguzzi C, Ferrari F, Cerezo P, Rossi S, Bonferoni MC, Dacarro C. Suitability assessment of tetracycline-loaded clays in the treatment of periodontitis. Proceedings of the 1stPharmSciFair, Pharmaceutical Sciences Fair and Exhibition. NICE, France PO-258 (2005).Google Scholar
    • 44 Wai KN, Banker GS. Some physicochemical properties of the montmorillonites. J. Pharm. Sci. 55, 1215–1220 (1966).Crossref, Medline, CASGoogle Scholar
    • 45 Fielden KE. US5556639 (1996).Google Scholar
    • 46 Viseras MT, Aguzzi C, Cerezo P, Viseras C, Lopez-Galindo A, Valenzuela C. Study of adsorption kinetics of 5-aminosalicilyc acid in phyllosilicates for controlled drug delivery in the treatment of inflammatory bowel disease. Pharmaceutical Sciences Fair and Exhibition. Nice, France, PO-253 (2005).Google Scholar
    • 47 Zhu Y, Adjei AL. US2002110527 (2002).Google Scholar
    • 48 Price RR, Gaber BP, Lvov Y. In vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dinucleotide from halloysite; a cylindrical mineral. J. Microencapsul. 18, 713–722 (2001).Crossref, Medline, CASGoogle Scholar
    • 49 Byrne R S, Deasy PB. Use of porous aluminosilicate pellets for drug delivery. J. Microencapsulation. 22, 423–437 (2005).Crossref, Medline, CASGoogle Scholar
    • 50 Levis SR, Deasy PB. Use of coated microtubular halloysite for the sustained release of hydrochloride and propranolol hydrochloride. Int. J. Pharm. 253, 145–157 (2003).Crossref, Medline, CASGoogle Scholar
    • 51 Lopez-Galindo A, Viseras C, Cerezo P. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci. 36, 51–63 (2007).Crossref, CASGoogle Scholar
    • 52 Arco MD, Fernández A, Martín C, Rives V. Release studies of different NSAIDs encapsulated in Mg,Al,Fe-hydrotalcites. App. Clay Sci. 42, 538–544 (2009).CrossrefGoogle Scholar
    • 53 Choy JH, Choi SJ, Oh JM, Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci. 36, 122–132 (2007).Crossref, CASGoogle Scholar
    • 54 Sironmani TA. Comparison of nanocarriers for gene delivery and nanosensing using montmorillonite, silver nanoparticles and multiwalled carbon nanotubes. Appl. Clay Sci. 103, 55–61 (2015).Crossref, CASGoogle Scholar
    • 55 Liu P. Polymer modified clay minerals: A review. Appl. Clay Sci. 38, 64–76 (2007).Crossref, CASGoogle Scholar
    • 56 Guggenheim S, Adams JM, Bain DC et al. Summary of recommendations of nomenclature committees relevant to clay mineralogy: report of the Association Internationale pour l'Etude des Argiles (AIPEA) Nomenclature Committee for 2006. Clay Minerals 41, 863–877 (2006).• Basics of clay minerals.Crossref, CASGoogle Scholar
    • 57 Chiu C, Huang T, Wang Y, Alamani B, Lin JJ. Intercalation strategies in clay/polymer hybrids. Progr. Polymer Sci. 39(3), 443–485 (2014).Crossref, CASGoogle Scholar
    • 58 Sposito G, Skipper NT, Sutton R, Park SH, Soper AK, Greathouse JA. Surface geochemistry of the clay minerals. Proc. Natl Acad. Sci. USA 96, 3358–3364 (1999).Crossref, Medline, CASGoogle Scholar